146 related articles for article (PubMed ID: 38126028)
1. Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC.
Koeck S; Amann A; Kern J; Zwierzina M; Lorenz E; Sopper S; Zwierzina H; Mildner F; Sykora M; Sprung S; Hackl H; Augustin F; Maier HT; Pircher A; Pall G; Wolf D; Gamerith G
Oncoimmunology; 2023; 12(1):2274130. PubMed ID: 38126028
[TBL] [Abstract][Full Text] [Related]
2. The influence of stromal cells and tumor-microenvironment-derived cytokines and chemokines on CD3
Koeck S; Kern J; Zwierzina M; Gamerith G; Lorenz E; Sopper S; Zwierzina H; Amann A
Oncoimmunology; 2017; 6(6):e1323617. PubMed ID: 28680763
[TBL] [Abstract][Full Text] [Related]
3. Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer.
Wang L; Yang H; Dorn P; Berezowska S; Blank F; Wotzkow C; Marti TM; Peng RW; Harrer N; Sommergruber W; Kocher GJ; Schmid RA; Hall SRR
EBioMedicine; 2021 Nov; 73():103664. PubMed ID: 34740105
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
6. Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation.
Moreno-Ruiz P; Corvigno S; Te Grootenhuis NC; La Fleur L; Backman M; Strell C; Mezheyeuski A; Hoelzlwimmer G; Klein C; Botling J; Micke P; Östman A
Lung Cancer; 2021 May; 155():10-19. PubMed ID: 33706022
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
8. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.
Rudisch A; Dewhurst MR; Horga LG; Kramer N; Harrer N; Dong M; van der Kuip H; Wernitznig A; Bernthaler A; Dolznig H; Sommergruber W
PLoS One; 2015; 10(4):e0124283. PubMed ID: 25919140
[TBL] [Abstract][Full Text] [Related]
9. MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
Eiro N; Cid S; Aguado N; Fraile M; de Pablo N; Fernández B; Domínguez F; González LO; Vizoso FJ
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396463
[TBL] [Abstract][Full Text] [Related]
10. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
Chen G; Dong Z; Wu D; Chen Y
J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
[TBL] [Abstract][Full Text] [Related]
12. Epidermal Growth Factor Receptor Mutations in Resectable Non-Small Cell Lung Cancer Patients and their Potential Role in the Immune Landscape.
Xia W; Mao W; Chen R; Lu R; Liu F; He Y; Wang S; Li X; Zheng M
Med Sci Monit; 2019 Nov; 25():8764-8776. PubMed ID: 31746315
[TBL] [Abstract][Full Text] [Related]
13. Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients.
Bruschini S; Pallocca M; Sperandio E; D'Ambrosio L; Ascenzi F; De Vitis C; Salvati V; Esposito A; Di Martino S; De Nicola F; Paolini F; Fattore L; Alessandrini G; Facciolo F; Foddai ML; Bassi M; Venuta F; D'Ascanio M; Ricci A; D' Andrilli A; Napoli C; Aurisicchio L; Fanciulli M; Rendina EA; Ciliberto G; Mancini R
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35584864
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of RILPL2 and its correlation with tumor immune microenvironment and glycolysis in non-small cell lung cancer.
Chen D; Zhang H; Zhao L; Liu X; Xue S; Wu P; Jiang H
Cell Cycle; 2023 Apr; 22(7):841-857. PubMed ID: 36536539
[TBL] [Abstract][Full Text] [Related]
15. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
Koukourakis MI; Giatromanolaki A; Kakolyris S; O'Byrne KJ; Apostolikas N; Skarlatos J; Gatter KC; Harris AL
Br J Cancer; 1998 May; 77(10):1696-703. PubMed ID: 9635852
[TBL] [Abstract][Full Text] [Related]
16. Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
Kilvaer TK; Rakaee M; Hellevik T; Østman A; Strell C; Bremnes RM; Busund LT; Dønnem T; Martinez-Zubiaurre I
PLoS One; 2018; 13(2):e0192157. PubMed ID: 29415055
[TBL] [Abstract][Full Text] [Related]
17. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J
Front Immunol; 2023; 14():1217590. PubMed ID: 37492563
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta.
O'Connor RA; Martinez BR; Koppensteiner L; Mathieson L; Akram AR
Front Immunol; 2023; 14():1221532. PubMed ID: 37520560
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
[TBL] [Abstract][Full Text] [Related]
20. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.
Kim SH; Choe C; Shin YS; Jeon MJ; Choi SJ; Lee J; Bae GY; Cha HJ; Kim J
Anticancer Res; 2013 May; 33(5):2001-9. PubMed ID: 23645749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
